Scopio Labs
Tel Aviv, Israel· Est.
AI‑driven full‑field digital microscopy platform for hematology diagnostics.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
AI‑driven full‑field digital microscopy platform for hematology diagnostics.
HematologyOncology
Technology Platform
Computational photography combined with deep‑learning AI to capture full‑field 100x whole‑slide images and provide automated cell morphology analysis.
Opportunities
Expansion into additional hematology and oncology diagnostics, integration with laboratory information systems, and growth of remote tele‑consultation services.
Risk Factors
Regulatory hurdles in new markets, adoption resistance from legacy labs, and competition from established digital pathology vendors.
Competitive Landscape
Competes with imaging giants such as Philips, Leica, and Hamamatsu, but differentiates through full‑field 100x imaging and AI‑driven autonomous analysis.